Thomas Walsh

1.8k total citations · 1 hit paper
48 papers, 1.2k citations indexed

About

Thomas Walsh is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Thomas Walsh has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Infectious Diseases and 13 papers in Applied Microbiology and Biotechnology. Recurrent topics in Thomas Walsh's work include Antibiotic Use and Resistance (13 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Thomas Walsh is often cited by papers focused on Antibiotic Use and Resistance (13 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Thomas Walsh collaborates with scholars based in United States, Australia and Greece. Thomas Walsh's co-authors include Brett Hanscom, Jon D. Lurie, James N. Weinstein, Peter J. Kudenchuk, Carol Fahrenbruch, William A. Murray, Richard O. Cummins, Loren Cobb, Michele Olsufka and Michael K. Copass and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Thomas Walsh

45 papers receiving 1.1k citations

Hit Papers

Amiodarone for Resuscitation after Out-of-Hospital Cardia... 1999 2026 2008 2017 1999 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
    1999 489 citations Thomas Walsh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Walsh United States 17 362 311 230 229 214 48 1.2k
Spyros D. Mentzelopoulos Greece 21 961 2.7× 141 0.5× 173 0.8× 200 0.9× 393 1.8× 77 2.0k
Sten Walther Sweden 24 326 0.9× 155 0.5× 92 0.4× 233 1.0× 454 2.1× 98 1.9k
Keith D. Wrenn United States 20 356 1.0× 164 0.5× 116 0.5× 178 0.8× 296 1.4× 31 1.4k
Nicolas Mongardon France 21 1.3k 3.7× 355 1.1× 363 1.6× 522 2.3× 760 3.6× 99 2.9k
Simon W. Lam United States 22 144 0.4× 126 0.4× 164 0.7× 345 1.5× 698 3.3× 105 1.5k
Frank Bloos Germany 27 256 0.7× 284 0.9× 87 0.4× 520 2.3× 950 4.4× 75 2.3k
Lidia Dalfino Italy 17 177 0.5× 251 0.8× 320 1.4× 415 1.8× 434 2.0× 45 1.4k
P Malacarne Italy 25 260 0.7× 61 0.2× 490 2.1× 386 1.7× 433 2.0× 93 2.4k
Shailesh Bihari Australia 24 310 0.9× 242 0.8× 126 0.5× 572 2.5× 912 4.3× 126 2.6k
John Papadopoulos United States 19 169 0.5× 239 0.8× 190 0.8× 168 0.7× 263 1.2× 93 1.1k

Countries citing papers authored by Thomas Walsh

Since Specialization
Citations

This map shows the geographic impact of Thomas Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Walsh more than expected).

Fields of papers citing papers by Thomas Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Walsh. The network helps show where Thomas Walsh may publish in the future.

Co-authorship network of co-authors of Thomas Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Walsh. A scholar is included among the top collaborators of Thomas Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Walsh. Thomas Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bremmer, Derek N., et al.. (2023). Analysis of a beta-lactam allergy assessment protocol challenging diverse reported allergies managed by an antimicrobial stewardship program. SHILAP Revista de lepidopterología. 3(1). e153–e153. 2 indexed citations
2.
3.
Walsh, Thomas, et al.. (2022). Factors Associated With Acceptance of Telehealth-Based Antimicrobial Stewardship Program Recommendations in a Community Hospital Health System. Open Forum Infectious Diseases. 9(9). ofac458–ofac458. 3 indexed citations
4.
Bremmer, Derek N., et al.. (2022). Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status. Open Forum Infectious Diseases. 9(9). ofac438–ofac438. 4 indexed citations
5.
Bremmer, Derek N., et al.. (2021). Effectiveness of Dalbavancin Compared With Standard of Care for the Treatment of Osteomyelitis: A Real-world Analysis. Open Forum Infectious Diseases. 9(2). ofab589–ofab589. 20 indexed citations
6.
7.
8.
9.
Walsh, Thomas, et al.. (2019). Impact of a Telehealth-Based Antimicrobial Stewardship Program in a Community Hospital Health System. Clinical Infectious Diseases. 71(3). 539–545. 29 indexed citations
10.
Walsh, Thomas, et al.. (2019). The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States. Clinical Toxicology. 57(11). 1064–1072. 11 indexed citations
11.
Walsh, Thomas, et al.. (2019). The impact of the Hospital Elder Life Program on the treatment of asymptomatic bacteriuria: An unexpected benefit. Geriatric Nursing. 40(5). 473–477. 1 indexed citations
12.
Walsh, Thomas, et al.. (2019). Community-acquired Pneumonia Secondary to Legionella pneumophila and Streptococcus pneumoniae: A Rare Co-infection. Cureus. 11(2). e4080–e4080. 5 indexed citations
13.
Walsh, Thomas, et al.. (2017). Effect of Antimicrobial Stewardship Program Guidance on the Management of Uncomplicated Skin and Soft Tissue Infections in Hospitalized Adults. SHILAP Revista de lepidopterología. 1(1). 91–99. 10 indexed citations
14.
Walsh, Thomas, et al.. (2017). Creeping Skin Lesions: Primary Cutaneous Cryptococcosis. The American Journal of Medicine. 130(6). 666–668. 1 indexed citations
15.
Walsh, Thomas, et al.. (2017). Neisseria cinerea bacteremia in a patient receiving eculizumab: a case report. Infection. 46(2). 271–274. 6 indexed citations
16.
Walsh, Thomas, et al.. (2016). Risk Factors for Surgical Site Infections Following Neurosurgical Spinal Fusion Operations: A Case Control Study. Infection Control and Hospital Epidemiology. 38(3). 340–347. 19 indexed citations
17.
Walsh, Thomas, et al.. (2016). Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infectious Diseases. 16(1). 721–721. 34 indexed citations
18.
Olson, Patrick R., Jon D. Lurie, John W. Frymoyer, et al.. (2011). Lumbar Disc Herniation in the Spine Patient Outcomes Research Trial. Spine. 36(26). 2324–2332. 18 indexed citations
19.
Walsh, Thomas, Brett Hanscom, Jon D. Lurie, & James N. Weinstein. (2003). Is a Condition-Specific Instrument for Patients with Low Back Pain/Leg Symptoms Really Necessary?. Spine. 28(6). 607–615. 161 indexed citations
20.
Walsh, Thomas. (2003). Custom Removable Immediate Postoperative Prosthesis. JPO Journal of Prosthetics and Orthotics. 15(4). 158–161. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Spyros D. Mentzelopoulos Breakdown of academic impact, for papers by Sten Walther Breakdown of academic impact, for papers by Keith D. Wrenn Breakdown of academic impact, for papers by Nicolas Mongardon Breakdown of academic impact, for papers by Simon W. Lam Breakdown of academic impact, for papers by Frank Bloos Breakdown of academic impact, for papers by Lidia Dalfino Breakdown of academic impact, for papers by P Malacarne Breakdown of academic impact, for papers by Shailesh Bihari Breakdown of academic impact, for papers by John Papadopoulos
Rankless by CCL
2026